Ftse Mib
33.739,90
-0,08%
DAX
19.848,77
-0,34%
S&P 500
6.040,04
1,10%
NASDAQ
20.031,13
1,35%
Bitcoin
98.091,07
-1,22%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Osmotica Pharmaceuticals PLC (OSMT) Osmotica Pharmaceuticals PLC (OSMT) Notizie

OSMT

Osmotica Pharmaceuticals (OSMT)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:OSMT
DataOraFonteTitoloSimboloCompagnia
16/06/202322:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
11/05/202322:24Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
24/04/202322:26Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
24/04/202322:17Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
24/04/202322:13Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
08/03/202322:26Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
27/01/202322:11Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
26/01/202323:17Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
12/08/202222:07Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
11/08/202221:53Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
09/08/202223:21Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
12/04/202223:05Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
30/03/202222:52Edgar (US Regulatory)Annual Report (10-k)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
19/01/202217:38GlobeNewswire Inc.UPDATE – Osmotica Pharmaceuticals plc Announces Corporate Name Change to RVL Pharmaceuticals plc, New Ticker Symbol “RVLP,” Plans to Launch UPNEEQ® into the Medical Aesthetics Market, and Provides Fourth Quarter 2022 Net Sales GuidanceNASDAQ:OSMTOsmotica Pharmaceuticals PLC
19/01/202212:50GlobeNewswire Inc.Osmotica Pharmaceuticals plc Announces Corporate Name Change to RVL Pharmaceuticals plc, New Ticker Symbol “RVLP,” Plans to Launch UPNEEQ® into the Medical Aesthetics Market, and Provides Fourth Quarter 2022 Net Sales GuidanceNASDAQ:OSMTOsmotica Pharmaceuticals PLC
18/01/202212:50GlobeNewswire Inc.RVL Pharmaceuticals to Host UPNEEQ® Overview and Business Update Webcast on January 19, 2022NASDAQ:OSMTOsmotica Pharmaceuticals PLC
06/01/202214:55GlobeNewswire Inc.Osmotica Pharmaceuticals plc to Host UPNEEQ® Overview and Business Update Call on January 19, 2022NASDAQ:OSMTOsmotica Pharmaceuticals PLC
23/12/202112:15TipRanksH.C. Wainwright Thinks Osmotica Pharmaceuticals’ Stock is Going to RecoverNASDAQ:OSMTOsmotica Pharmaceuticals PLC
20/12/202122:05GlobeNewswire Inc.Osmotica Pharmaceuticals plc to Present at H.C. Wainwright Bioconnect ConferenceNASDAQ:OSMTOsmotica Pharmaceuticals PLC
16/11/202123:13Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
15/11/202122:05GlobeNewswire Inc.Osmotica Pharmaceuticals plc Reports Third Quarter 2021 Results and Provides Business UpdateNASDAQ:OSMTOsmotica Pharmaceuticals PLC
15/11/202112:50GlobeNewswire Inc.Osmotica Pharmaceuticals plc to Present at Jefferies London Virtual Healthcare Conference 2021NASDAQ:OSMTOsmotica Pharmaceuticals PLC
12/11/202101:30GlobeNewswire Inc.Osmotica Pharmaceuticals plc to Provide Third Quarter 2021 Business and Financial Update on November 15, 2021NASDAQ:OSMTOsmotica Pharmaceuticals PLC
22/10/202122:28Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
13/10/202122:45GlobeNewswire Inc.Osmotica Pharmaceuticals plc Announces Closing of $35 Million Underwritten Public OfferingNASDAQ:OSMTOsmotica Pharmaceuticals PLC
08/10/202123:14Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
07/10/202115:04GlobeNewswire Inc.Osmotica Pharmaceuticals plc Announces Debt Financing from Athyrium Capital Management of up to $100 MillionNASDAQ:OSMTOsmotica Pharmaceuticals PLC
07/10/202106:31GlobeNewswire Inc.Osmotica Pharmaceuticals Announces Pricing of $35 Million Underwritten Public OfferingNASDAQ:OSMTOsmotica Pharmaceuticals PLC
06/10/202122:26GlobeNewswire Inc.Osmotica Pharmaceuticals plc Announces Proposed Underwritten Public OfferingNASDAQ:OSMTOsmotica Pharmaceuticals PLC
22/09/202123:00GlobeNewswire Inc.Osmotica Pharmaceuticals plc to Present at Cantor Virtual Global Healthcare Conference 2021NASDAQ:OSMTOsmotica Pharmaceuticals PLC
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:OSMT

La tua Cronologia

BOV
QCOM34
Qualcomm
BIT
NSCIT4664057
BNP Paribas
BIT
NSCIT35087H4
Canada
BOV
IFIX
Real Estate Investment
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network